- What is InsuLine Medical's primary product?
- InsuLine Medical's flagship product is the InsuPad, a device designed to improve insulin absorption by gently warming the skin to increase blood flow. It consists of a disposable injection window and a reusable control unit.
- When was InsuLine Medical founded?
- InsuLine Medical was founded in February 2007.
- What is the current status of InsuLine Medical?
- InsuLine Medical is currently inactive and ceased to operate in June 2019.
- How much total funding has InsuLine Medical raised?
- InsuLine Medical has raised a total of $6,500,000 USD across its funding rounds.
- When was InsuLine Medical's last funding round and who invested?
- InsuLine Medical's last funding round was in August 2018, with IBI Investment House participating.
- Which investors participated in InsuLine Medical's April 2012 funding round?
- Pontifax participated in InsuLine Medical's funding round in April 2012.
- In which countries did InsuLine Medical initiate commercialization of its InsuPad product?
- InsuLine Medical initiated commercialization of the InsuPad in Germany, in collaboration with J&J (LifeScan), and in Israel, with DYN diagnostics.
- What is InsuLine Medical's employee count?
- InsuLine Medical has an employee count in the 1-10 range.